Impact of preservation solution on early function and graft survival in cadaveric renal transplantation.
Albrecht
K
K
Department of General Surgery, University Hospitals, Essen, Germany.
Zühlke
M
M
Kruschke
A
A
Eigler
F W
FW
D000241:Adenosine; D000328:Adult; D000493:Allopurinol; D002102:Cadaver; D005260:Female; D005500:Follow-Up Studies; D005947:Glucose; D005978:Glutathione; D006085:Graft Survival; D006801:Humans; D006982:Hypertonic Solutions; D007328:Insulin; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008353:Mannitol; D008875:Middle Aged; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions; D011189:Potassium Chloride; D011343:Procaine; D011887:Raffinose; D013997:Time Factors; D014019:Tissue Donors
C039984:Bretschneider cardioplegic solution; C037096:Euro-Collins' solution; D006982:Hypertonic Solutions; D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D008353:Mannitol; D011343:Procaine; D000493:Allopurinol; D011189:Potassium Chloride; D005978:Glutathione; D005947:Glucose; D000241:Adenosine; D011887:Raffinose